We are pleased to announce the appointment of Nagihan ŞENGÜL KARPUZ to Board of Directors

We are pleased to announce the appointment of Nagihan ŞENGÜL KARPUZ to Board of Directors
(PresseBox) ( Leinfelden-Ecterdingen, )
VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of Nagihan ŞENGÜL KARPUZ to the company’s Board of Directors.

Nagihan Şengül Karpuz has been appointed Board Member of VSY Biotechnology. She began her carrier at E&Y and has spent most of her career at Yıldız Holding, working in various areas related to tax compliance, tax policies, IFRS reporting, financial consolidation, global insurance management, budget, accounting and financial performance reporting processes. She recently has founded NSK Strategic Consultancy Company after leaving her latest role as Vice President of Financial Affairs of of Yıldız Holding.

Nagihan holds a degree in Economics from Middle East Technical University and  MBA in Business Administration from Yeditepe University.

“VSY Biotechnology provides me with an exciting opportunity to work with a highly committed and professional executive team to deliver on an ambitious global growth strategy,” she said.

VSY Biotechnology Chairman Dr. Ercan Varlibas said: “Nagihan’s wide experience at companies and her strong background in audit and financial control will be valuable assets in the next stages of VSY Biotechnology’s development. Everyone at VSY Biotechnology looks forward to welcoming her to the team.”
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.